RxDoctor Payments Data

Owen Debowy, MD

Pediatrics · Plainville, MANPI 1518126713

Payments from drug & device makers

$3,021in general payments, 2019–2025

Across 156 payments — averaging $19.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$612
  • Novo Nordisk$396
  • Pfizer$351
  • Boehringer Ingelheim$186
  • Lilly USA, LLC$155
  • Exact Sciences$137
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$2,97198%
  • Other$502%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,021 in reported general payments places this provider in the 95th percentile of 1,444 pediatrics providers in Massachusetts.

See all pediatrics providers in Massachusetts

Medicare billing

Part B allowed, 2024
$111,469
Medicare patients
340
Services billed
1,332

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin72$67,978
TrulicityDulaglutide50$67,237
OzempicSemaglutide31$47,184
EliquisApixaban45$40,726
FarxigaDapagliflozin Propanediol26$32,092
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$15,572
DapagliflozinDapagliflozin Propanediol13$11,876
Breo ElliptaFluticasone/Vilanterol18$6,658
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$6,479
DuleraMometasone/Formoterol17$6,367
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog18$5,167
Advair HfaFluticasone Propion/Salmeterol11$3,923
Atorvastatin Calcium335$3,898
Rosuvastatin Calcium77$3,104
Omeprazole192$2,961

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$186$67,97872 claims
Lilly USA, LLCTrulicity$155$67,23750 claims
Novo NordiskOzempic$396$47,18431 claims
PfizerEliquis$351$40,72645 claims
AstraZenecaFarxiga$612$32,09226 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$125$28,70957 claims
MerckDulera$95$6,36717 claims
AbbVieSynthroid$78$1,10215 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,444 pediatrics providers in Massachusetts.

Other pediatrics in Plainville

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →